Elaine Weiner

1.6k total citations
20 papers, 409 citations indexed

About

Elaine Weiner is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Elaine Weiner has authored 20 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Elaine Weiner's work include Schizophrenia research and treatment (7 papers), Smoking Behavior and Cessation (5 papers) and Treatment of Major Depression (4 papers). Elaine Weiner is often cited by papers focused on Schizophrenia research and treatment (7 papers), Smoking Behavior and Cessation (5 papers) and Treatment of Major Depression (4 papers). Elaine Weiner collaborates with scholars based in United States and Israel. Elaine Weiner's co-authors include Robert W. Buchanan, M. Patricia Ball, James M. Gold, Robert P. McMahon, Deanna L. Kelly, Ann Summerfelt, William T. Carpenter, Melanie E. Bennett, Monica C. Mann-Wrobel and Robert R. Conley and has published in prestigious journals such as American Journal of Psychiatry, Social Forces and Neuropsychopharmacology.

In The Last Decade

Elaine Weiner

20 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elaine Weiner United States 11 170 152 101 72 56 20 409
Rosa Dueñas Spain 12 330 1.9× 74 0.5× 29 0.3× 170 2.4× 30 0.5× 21 525
Tae Kyou Choi South Korea 8 151 0.9× 77 0.5× 38 0.4× 259 3.6× 57 1.0× 10 507
Alejandro Jiménez‐Genchi Mexico 9 60 0.4× 77 0.5× 82 0.8× 58 0.8× 29 0.5× 23 358
Jan‐Henry Stenberg Finland 11 190 1.1× 32 0.2× 24 0.2× 85 1.2× 56 1.0× 32 398
Jozef Peuskens Belgium 11 187 1.1× 30 0.2× 31 0.3× 152 2.1× 34 0.6× 28 423
Manuel Canal‐Rivero Spain 14 236 1.4× 37 0.2× 31 0.3× 137 1.9× 37 0.7× 36 382
Hideaki Tani Japan 12 184 1.1× 25 0.2× 24 0.2× 97 1.3× 44 0.8× 36 384
Justine Lalonde United States 9 338 2.0× 49 0.3× 24 0.2× 185 2.6× 36 0.6× 11 540
Marcel Sieberer Germany 13 60 0.4× 39 0.3× 75 0.7× 145 2.0× 49 0.9× 33 461
P. Courtet France 8 113 0.7× 39 0.3× 77 0.8× 209 2.9× 50 0.9× 20 407

Countries citing papers authored by Elaine Weiner

Since Specialization
Citations

This map shows the geographic impact of Elaine Weiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Weiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Weiner more than expected).

Fields of papers citing papers by Elaine Weiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Weiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Weiner. The network helps show where Elaine Weiner may publish in the future.

Co-authorship network of co-authors of Elaine Weiner

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Weiner. A scholar is included among the top collaborators of Elaine Weiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Weiner. Elaine Weiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Megan, Heather A. Adams, Elaine Weiner, et al.. (2022). 25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemia. Journal of Psychiatric Research. 151. 25–29. 2 indexed citations
2.
Buchanan, Robert W., Deanna L. Kelly, Gregory P. Strauss, et al.. (2021). Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia. Journal of Clinical Psychopharmacology. 41(3). 236–243. 17 indexed citations
3.
Buchanan, Robert W., Elaine Weiner, Deanna L. Kelly, et al.. (2020). Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 40(5). 444–450. 8 indexed citations
4.
Savage, Christina, Gregory P. Strauss, Heather A. Adams, et al.. (2020). A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social Affiliation. Schizophrenia Bulletin Open. 1(1). sgaa001–sgaa001. 7 indexed citations
5.
Buchanan, Robert W., Deanna L. Kelly, Elaine Weiner, et al.. (2017). A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia. Journal of Clinical Psychopharmacology. 37(4). 394–400. 29 indexed citations
6.
Wehring, Heidi J., Stephen J. Heishman, Robert P. McMahon, et al.. (2017). Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia. Journal of Dual Diagnosis. 13(1). 36–42. 7 indexed citations
7.
Buchanan, Robert W., Elaine Weiner, Deanna L. Kelly, et al.. (2014). Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 41(4). 900–908. 16 indexed citations
8.
Weiner, Elaine & Saeed Ahmed. (2013). Smoking Cessation in Schizophrenia. Current Psychiatry Reviews. 9(2). 164–172. 5 indexed citations
9.
Weiner, Elaine, M. Patricia Ball, Alison Buchholz, et al.. (2011). Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia. The Journal of Clinical Psychiatry. 73(1). 95–102. 38 indexed citations
10.
Mann-Wrobel, Monica C., Melanie E. Bennett, Elaine Weiner, Robert W. Buchanan, & M. Patricia Ball. (2010). Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. Schizophrenia Research. 126(1-3). 277–283. 40 indexed citations
11.
Weiner, Elaine, Robert R. Conley, M. Patricia Ball, et al.. (2010). Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine. Neuropsychopharmacology. 35(11). 2274–2283. 38 indexed citations
12.
Kelly, Deanna L., Robert P. McMahon, Elaine Weiner, et al.. (2008). Lack of beneficial galantamine effect for smoking behavior: A double-blind randomized trial in people with schizophrenia. Schizophrenia Research. 103(1-3). 161–168. 28 indexed citations
13.
Weiner, Elaine, et al.. (2008). Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study. Journal of Psychopharmacology. 23(4). 436–441. 19 indexed citations
14.
Fischer, Bernard A. & Elaine Weiner. (2008). Clozapine Levels Lowered by Modafinil: A Case Report and Brief Review of Modafinil in Schizophrenia. Clinical Schizophrenia & Related Psychoses. 2(1). 88–90. 1 indexed citations
15.
Weiner, Elaine. (2007). Market Dreams. University of Michigan Press eBooks. 19 indexed citations
16.
Buchanan, Robert W., M. Patricia Ball, Elaine Weiner, et al.. (2004). Olanzapine Treatment of Residual Positive and Negative Symptoms. American Journal of Psychiatry. 162(1). 124–129. 35 indexed citations
17.
Weiner, Elaine, et al.. (2003). A comparison of bupropion SR and placebo for smoking cessation in schizophrenia. Schizophrenia Research. 60(1). 305–306. 6 indexed citations
18.
Buchanan, Robert W., et al.. (2003). Olanzapine treatment of residual positive and negative symptoms. Schizophrenia Research. 60(1). 275–275. 3 indexed citations
19.
Weiner, Elaine, M. Patricia Ball, Ann Summerfelt, James M. Gold, & Robert W. Buchanan. (2001). Effects of Sustained-Release Bupropion and Supportive Group Therapy on Cigarette Consumption in Patients With Schizophrenia. American Journal of Psychiatry. 158(4). 635–637. 90 indexed citations
20.
Kennedy, Michael D., et al.. (1999). Czechoslovakia 1918-1992: A Laboratory for Social Change.. Social Forces. 77(4). 1658–1658. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Dueñas Breakdown of academic impact, for papers by Tae Kyou Choi Breakdown of academic impact, for papers by Alejandro Jiménez‐Genchi Breakdown of academic impact, for papers by Jan‐Henry Stenberg Breakdown of academic impact, for papers by Jozef Peuskens Breakdown of academic impact, for papers by Manuel Canal‐Rivero Breakdown of academic impact, for papers by Hideaki Tani Breakdown of academic impact, for papers by Justine Lalonde Breakdown of academic impact, for papers by Marcel Sieberer Breakdown of academic impact, for papers by P. Courtet
Rankless by CCL
2026